A Novel COL4A5 Pathogenic Variant Joins the Dots in a Family with a Synchronous Diagnosis of Alport Syndrome and Polycystic Kidney Disease
Genes · 2024
DOI: 10.3390/genes15050597 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2024. Verfasst von Ludovico Graziani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy. Hauptthemen laut MEDLINE: Collagen Type IV, Nephritis, Hereditary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Ministero della Salute FSC 2014–2020.
Abstract (Originalsprache)
Alport Syndrome (AS) is the most common genetic glomerular disease, and it is caused by COL4A3, COL4A4, and COL4A5 pathogenic variants. The classic phenotypic spectrum associated with AS ranges from isolated hematuria to chronic kidney disease (CKD) with extrarenal abnormalities. Atypical presentation of the disorder is possible, and it can mislead the diagnosis. Polycystic kidney disease (PKD), which is most frequently associated with Autosomal Dominant PKD (ADPKD) due to PKD1 and PKD2 heterozygous variants, is emerging as a possible clinical manifestation in COL4A3-A5 patients. We describe a COL4A5 novel familial frameshift variant (NM_000495.5: c.1095dup p.(Leu366ValfsTer45)), which was associated with AS and PKD in the hemizygous proband, as well as with PKD, IgA glomerulonephritis and focal segmental glomerulosclerosis (FSGS) in the heterozygous mother. Establishing the diagnosis of AS can sometimes be difficult, especially in the context of misleading family history and atypical phenotypic features. This case study supports the emerging genotypic and phenotypic heterogeneity in COL4A3-A5-associated disorders, as well as the recently described association between PKD and collagen type IV (Col4) defects. We highlight the importance of the accurate phenotyping of all family members and the relevance of next-generation sequencing in the differential diagnosis of hereditary kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.
- Medical Genetics Unit, Tor Vergata University Hospital, 00133 Rome, Italy.
- Division of Nephrology, Department of Translational and Precision Medicine, "Sapienza" University, 00133 Rome, Italy.
- Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.
ORCID-Profile: Ludovico Graziani, Chiara Minotti, Miriam Lucia Carriero, Silvia Lai, Antonio Novelli, Giuseppe Novelli
Förderung
- Ministero della Salute
- Ministero della Salute FSC 2014–2020
Zitieren
APA
Graziani, L., Minotti, C., Carriero, M. L., Bengala, M., Lai, S., Terracciano, A., Novelli, A., & Novelli, G. (2024). A Novel COL4A5 Pathogenic Variant Joins the Dots in a Family with a Synchronous Diagnosis of Alport Syndrome and Polycystic Kidney Disease. Genes. https://doi.org/10.3390/genes15050597
Vancouver
Graziani L, Minotti C, Carriero ML, Bengala M, Lai S, Terracciano A, et al. A Novel COL4A5 Pathogenic Variant Joins the Dots in a Family with a Synchronous Diagnosis of Alport Syndrome and Polycystic Kidney Disease. Genes. 2024. doi:10.3390/genes15050597
BibTeX
@article{Graziani2024,
author = {Graziani, Ludovico and Minotti, Chiara and Carriero, Miriam Lucia and Bengala, Mario and Lai, Silvia and Terracciano, Alessandra and Novelli, Antonio and Novelli, Giuseppe},
title = {A Novel COL4A5 Pathogenic Variant Joins the Dots in a Family with a Synchronous Diagnosis of Alport Syndrome and Polycystic Kidney Disease},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15050597}
}
EUVIMED